| 000 | 01210 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250512014230.0 | ||
| 264 | 0 | _c19890614 | |
| 008 | 198906s 0 0 eng d | ||
| 022 | _a0277-5379 | ||
| 024 | 7 |
_a10.1016/0277-5379(89)90204-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBuc-Calderon, P | |
| 245 | 0 | 0 |
_aIncreasing therapeutic effect and reducing toxicity of doxorubicin by N-acyl dehydroalanines. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer & clinical oncology _cApr 1989 |
||
| 300 |
_a679-85 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAlanine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAlanine Transaminase _xblood |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAspartate Aminotransferases _xblood |
| 650 | 0 | 4 |
_aBone Marrow _xdrug effects |
| 650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
| 650 | 0 | 4 |
_aLeukemia L1210 _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 700 | 1 | _aPraet, M | |
| 700 | 1 | _aRuysschaert, J M | |
| 700 | 1 | _aRoberfroid, M | |
| 773 | 0 |
_tEuropean journal of cancer & clinical oncology _gvol. 25 _gno. 4 _gp. 679-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0277-5379(89)90204-6 _zAvailable from publisher's website |
| 999 |
_c2720222 _d2720222 |
||